Sarah Cannon, SCRI Oncology Partners
Sarah Cannon, SCRI Oncology Partners
Nashville, Tennessee, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Disease Progression, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, astrocytoma (excluding glioblastoma), colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, glioblastoma, glioma, intestinal disorder, lung cancer, lung disorder, lung neoplasm, malignant colon neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2026-06-23 | NCT04678648 |